Peripheral neuropathy Board decisions

The Veteran's service-connected disabilities prevented him from securing and following a substantially gainful occupation from September 1, 2013 to February 9, 2015.

The Veteran's claims for increased ratings for diabetes mellitus, type II and diabetic nephropathy were denied. The Veteran's peripheral neuropathy of the right upper extremity (RUE) was also denied a higher rating.

The Board has remanded the Veteran's claims for service connection for peripheral neuropathy of both lower extremities, as due to herbicide agent exposure. The VA examiner is requested to provide opinions regarding whether any lower extremity nerve disorder had onset in service, manifested within one year after service discharge, or was otherwise related to service, to include herbicide exposure.

The Veteran's claims for service connection for peripheral neuropathy of the bilateral upper and lower extremities have been remanded due to new evidence suggesting current diagnoses but conflicting with previous examinations. The Board requests a VA examination to determine if early onset or herbicide exposure is related.

The Veteran's right upper extremity peripheral neuropathy is rated at 30 percent from April 12, 2010. The left upper extremity peripheral neuropathy remains rated at 20 percent.

The Board has ordered a new medical opinion to determine if the Veteran's back disorder and neurological symptoms are related to service, including exposure during the Gulf War. The claim is being remanded for this purpose.

The Veteran's claims for service connection for polyneuropathy of the bilateral upper and lower extremities have been remanded due to insufficient evidence. The Board requests an updated VA examination to determine if the condition is related to his military service or caused by his service-connected eczema and psoriasis.

The Veteran's prostate condition, including BPH, is not related to his active-duty service.,The Veteran's peripheral neuropathy of the left lower extremity is related to his presumed Agent Orange exposure.

The Board has remanded the Veteran's claims for service connection for diabetes mellitus, type II and peripheral neuropathy of the upper and lower extremities, as well as his claim for TDIU due to unresolved issues regarding exposure to herbicides in Guam.

The Board has remanded the Veteran's claims for service connection due to insufficient evidence regarding in-service injuries and exposure. The cases are returned to the AOJ for further development.

The Board denied service connection for bilateral peripheral neuropathy of the lower extremities, finding no evidence linking the condition to military service or presumed herbicide exposure.

The Veteran's appeal is remanded for additional development to determine the extent of nerve impairment throughout the appeal period.

The Veteran's claims for service connection for left and right lower extremity peripheral neuropathy, as well as his claim for an increased rating for PTSD with major depressive disorder, are being remanded due to the need for additional examinations and opinions.

The Board has granted service connection for bilateral peripheral neuropathy of the upper and lower extremities, finding that the evidence is approximately evenly balanced as to whether these conditions are related to exposure to contaminated water at Camp Lejeune during active duty.

The Board dismissed the appeal due to the appellant's withdrawal of the appeal for bilateral lower extremity neuropathy.

The Board denied earlier effective dates for the grant of service connection for various lower extremity peripheral neuropathies, finding that no prior claims were filed before February 5, 2016.

The Veteran's service-connected disabilities did not prevent him from securing and following a substantially gainful occupation prior to June 12, 2017.

The Board has granted an initial disability rating of 20 percent for the Veteran's service-connected right peroneal neuropathy, finding that her symptoms are primarily manifested by severe pain and paresthesias, as well as moderate numbness, decreased strength and sensation, and impaired reflexes. The Board concluded that this level of impairment is more analogous to severe incomplete paralysis of the musculocutaneous (superficial peroneal) nerve.

The Veteran's appeal is remanded for additional development, including obtaining Social Security Taxes Earnings and a VA neurological examination by an appropriate clinician to evaluate the current severity of his CIDP.

The Board denied service connection for various conditions, including polyneuropathy of the upper and lower extremities and prostate cancer, attributing these to presumed exposure to toxic chemicals at Camp Lejeune. The evidence did not support a direct link between the Veteran's service and his current conditions.